A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Clinical trial NCT00035529 · TERMINATED

Trial details

NCT number: NCT00035529
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2001-11-01
Primary completion: 2003-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.